Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
GYRE
LXRX
Add up to 3 more stocks
GYRE
Gyre Therapeutics, Inc.
-2.45%
$7.17-0.18Delayed quote: Oct 6, 2026, 11:50 AM EDT
Market Cap
$799.38M
52W Range
$5.44 - $9.42
LXRX
Lexicon Pharmaceuticals, Inc.
+1.82%
$1.77+0.03Delayed quote: Oct 6, 2026, 11:50 AM EDT
Market Cap
$786.94M
52W Range
$0.51 - $2.68
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 7.41 | 4.51 |
| P/S Ratio | 6.70 | 18.98 |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 94.3% | 98.8% |
| Operating Margin | 9.9% | -98.2% |
| Net Margin | -14.5% | -147.4% |
| ROE | -13.3% | -35.0% |
| ROA | -8.7% | -24.4% |
| ROIC | -9.8% | -23.2% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 4.26 | 13.37 |
| Quick Ratio | 3.86 | 13.29 |
| Debt/Equity | 0.03 | 0.34 |
| Interest Coverage | N/A | -5.87 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.